Research briefs.
- Published in:
- Chemistry & Industry, 2007, n. 14, p. 8
- Publication type:
- Article
Works matching DE "DYAX Corp."
Results: 7
1
2
Orphan products.
- Published in:
- Applied Clinical Trials, 2003, v. 12, n. 11, p. 14
- Publication type:
- Article
3
Phase 2 trials.
- Published in:
- Applied Clinical Trials, 2002, v. 11, n. 11, p. 64
- Publication type:
- Article
4
Dyax backs albumin.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 7, p. 718, doi. 10.1038/nbt0708-718
- By:
- Publication type:
- Article
5
Companies line up for hereditary angioedema market.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 4, p. 364, doi. 10.1038/nbt0408-364
- By:
- Publication type:
- Article
6
In a rare deal, Shire buys Dyax.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 7
- Publication type:
- Article
7
FDA approves kallikrein inhibitor to treat hereditary angioedema.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, n. 2, p. 93, doi. 10.2146/news100005
- By:
- Publication type:
- Article